Startups have raised billions on the promise of disrupting healthcare.
To win over investors, startups often present their businesses through a slide deck.
Here are the presentations obtained by Insider that healthcare startups have used to raise millions.
In the past few years, investors have bet billions on healthcare startups looking to disrupt the industry.
In 2020 alone, healthcare startups raised $17 billion, according to Silicon Valley Bank.
Winning over investors can be a long process, and it often involves a slide deck that lays out what the startup does, and where the company is heading.
Insider rounded up all the presentations we've published that healthcare startups have used to raise cash from investors.
Early on, startups sell investors on often newly-tested ideas
When startup founders pitch investors ahead of a seed or Series A round, they haven't gotten far off the ground.
Presentations can be helpful at laying out the approach that startup is taking, or plans to take.
You can see more presentations below.
By Series B, startups are looking for a chance to grow big
By their Series B rounds, startups are raising higher sums at higher valuations. They're often still early into their existence and are looking for ways to get big.
For instance, Devoted Health raised $300 million at a $1.8 billion valuation in 2018 before it had signed on any customers.
Late-stage rounds can give startups the fuel to scale or gear up for a public debut
The presentations used to secure later rounds of funding can be used to show investors how far the startup's come, and what's ahead.
Often, the investors start to look different as well, and startups can find themselves pitching asset managers or industry incumbents, like health insurers.
For instance, Tiger Global and health insurer Humana backed at-home healthcare startup Dispatch Health in its Series D, while insurer Centene joined in on Hazel Health's Series C.
The funding rounds, such as Moderna's pitch to investors in 2017, can come shortly before plans to go public. Moderna made its public debut in 2018.
Read the original article on Business Insider